share_log

啓明醫療-B:2024年第二次臨時股東大會之股東代理人委任表格

VENUS MEDTECH-B: PROXY FORMFOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING

HKEX ·  Nov 19, 2024 17:04

Summary by Moomoo AI

啟明醫療-B將於2024年12月5日舉行2024年第二次臨時股東大會,地點為中國杭州濱江區。會議將審議包括選舉古軍華先生為獨立非執行董事在內的多項決議案。此外,股東將就修訂公司章程相關條款及授予董事會發行股份的一般性授權等事宜進行投票。股東代理人委任表格顯示,股東可委任代理人出席大會並代表其投票,而所有投票事宜均需於大會指定舉行時間的24小時前完成相關委任手續。
啟明醫療-B將於2024年12月5日舉行2024年第二次臨時股東大會,地點為中國杭州濱江區。會議將審議包括選舉古軍華先生為獨立非執行董事在內的多項決議案。此外,股東將就修訂公司章程相關條款及授予董事會發行股份的一般性授權等事宜進行投票。股東代理人委任表格顯示,股東可委任代理人出席大會並代表其投票,而所有投票事宜均需於大會指定舉行時間的24小時前完成相關委任手續。
Qiming Medical-B will hold its second extraordinary general meeting of shareholders for the year 2024 on December 5, 2024, in the Binjiang District of Hangzhou, China. The meeting will deliberate on multiple resolutions, including the election of Mr. Gu Junhua as an independent non-executive director. In addition, shareholders will vote on matters related to amending the company's articles of association and granting the board of directors a general authorization to issue shares. The shareholder proxy appointment form indicates that shareholders may appoint proxies to attend the meeting and vote on their behalf, with all voting matters requiring completion of relevant proxy procedures 24 hours before the designated meeting time.
Qiming Medical-B will hold its second extraordinary general meeting of shareholders for the year 2024 on December 5, 2024, in the Binjiang District of Hangzhou, China. The meeting will deliberate on multiple resolutions, including the election of Mr. Gu Junhua as an independent non-executive director. In addition, shareholders will vote on matters related to amending the company's articles of association and granting the board of directors a general authorization to issue shares. The shareholder proxy appointment form indicates that shareholders may appoint proxies to attend the meeting and vote on their behalf, with all voting matters requiring completion of relevant proxy procedures 24 hours before the designated meeting time.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more